CASP1 and chronic obstructive pulmonary disease: In contrast, SP treatment markedly suppressed the TXNIP and NLRP3 levels, with reduced active forms of caspase-1 and IL-1β in the lung tissues compared with those in mice with PPE/LPS-induced COPD.